The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-[1-(2-Ethylaminoethyl)-2-hexyl-1H-benzimidazol-5-yl]-N-hydroxyacrylamide dihydrochloride salt ID: ALA3216532
PubChem CID: 53364268
Max Phase: Preclinical
Molecular Formula: C20H32Cl2N4O2
Molecular Weight: 358.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCNCC.Cl.Cl
Standard InChI: InChI=1S/C20H30N4O2.2ClH/c1-3-5-6-7-8-19-22-17-15-16(10-12-20(25)23-26)9-11-18(17)24(19)14-13-21-4-2;;/h9-12,15,21,26H,3-8,13-14H2,1-2H3,(H,23,25);2*1H/b12-10+;;
Standard InChI Key: PGKBWDGSAZKENE-PFNYCKIMSA-N
Molfile:
RDKit 2D
28 27 0 0 0 0 0 0 0 0999 V2000
11.7896 -1.0380 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-6.2216 1.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9153 0.7255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6217 1.4865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2318 2.6643 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.5151 0.7033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.5596 1.2941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3215 1.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0552 2.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5559 2.6972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1425 3.7441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6552 -2.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1277 -4.3539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5974 -4.6579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9752 -5.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2896 -1.0380 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
2 5 2 0
2 6 1 0
6 7 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
8 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
10 13 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
8 17 1 0
23 24 1 0
26 27 1 0
25 26 1 0
24 25 1 0
12 23 1 0
4 14 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.49Molecular Weight (Monoisotopic): 358.2369AlogP: 3.29#Rotatable Bonds: 11Polar Surface Area: 79.18Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.44CX Basic pKa: 10.20CX LogP: 2.59CX LogD: 0.90Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.25Np Likeness Score: -0.82
References 1. Wang H, Yu N, Chen D, Lee KC, Lye PL, Chang JW, Deng W, Ng MC, Lu T, Khoo ML, Poulsen A, Sangthongpitag K, Wu X, Hu C, Goh KC, Wang X, Fang L, Goh KL, Khng HH, Goh SK, Yeo P, Liu X, Bonday Z, Wood JM, Dymock BW, Kantharaj E, Sun ET.. (2011) Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile., 54 (13): [PMID:21634430 ] [10.1021/jm2003552 ]